Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of topical cis-urocanic acid versus placebo and Protopic in atopic dermatitis
2010-023543-15Phase 2Completed
- Sponsor
- BioCis Pharma
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cis-Urocanic acid in atopic dermatitis (AD) (4 arms), sponsored by BioCis Pharma. Primary endpoints: Clinical Skin Assessment, Pruritus visual analogue scale and 4 more. Started Nov 2010; status: completed.
02
Drugs
cis-Urocanic acid
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2010-023543-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023543-15.